we are grateful that Dr Daniel Kramer, global scientific advisor immunogenicity at sanofi R&D and chairman of the European Immunogenicity Platform (EIP) is willing to offer this (30’) presentation and (15’) dialogue with you about “Immunogenicity of Biologics and its clinical consequences” Wednesday 01 October 01:30-02:30 pm (CEST).
All our members will receive an invitation with Webmeeting link. If you are interested, please join our members http://app.gmp.asso.fr/ or contact GMP board on our website for further information.
The GMP board.
FIRST GMP WEBINAR (Monday 01 October) : IMMUNOGENICITY